Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

December 31, 2001

Conditions
Postmenopause
Interventions
DRUG

CDB 2914

Trial Locations (1)

20892

National Institute of Child Health and Human Development (NICHD), Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00009659 - Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause | Biotech Hunter | Biotech Hunter